The White House is pressing Congress to take action to prevent the sweeping federal recriminalization of hemp products that will take effect later this year.
The push comes as part of a request to lawmakers for additional funding to help the administration cover costs related to attacks on Iran and “other critical needs,” such as responding to an Ebola outbreak in Africa.
“Furthermore, the Administration is seeking additional authorities that it strongly supports,” White House Office of Management and Budget Director Russell Vought wrote to House Speaker Mike Johnson (R-LA) on Wednesday.
“These authorities include a review of federal hemp regulations to ensure fair treatment of hemp products consistent with Amendment 54 offered to HR 8646 in the House Rules Committee, or at least an extension of the implementation of the regulatory framework established by Section 781 of Public Law 119-37,” he said.
The amendment Vought was referring to was introduced by Rep. Andy Barr (R-KY). It has kept many hemp products legal that will be re-criminalized this yearadded labeling requirements and implemented new sales taxes, among other regulatory reforms. However, the Rules Committee prevented it from receiving a House vote.
Barr is also preparing to introduce stand-alone legislation on the issue and has said she opposes a coalition of strange bedfellows. the alcohol industry, marijuana businesses and opponents of cannabis legalization.
An appendix to the White House’s letter to Congress this week notes that the hemp-related request would “update the statutory definition of hemp-derived cannabinoid end products to ensure Americans have access to appropriate full-spectrum CBD products while maintaining Congress’ intent to limit the sale of products that pose serious health risks.”
The the administration used hemp-like language Earlier this month, they blocked retention of Barr’s previous amendment to the administration’s policy statement on the farm funding bill.
Jonathan Miller, general counsel of the US Hemp Desk, told Marijuana Moment that the group is “pleased to see the president take a public stance in favor of replacing the hemp ban with a strong regulatory framework, or at least securing an extension of the hemp ban moratorium to give Congress more time to develop regulations.”
“This is an important step in fulfilling Congress’ commitment to help farmers and consumers,” he said.
Hemp derivatives with less than 0.3 percent delta-9 THC by dry weight were made federally legal under the 2018 Farm Bill signed by Trump during his first term. But late last year, he signed new legislation with provisions that will redefine hemp, so that only products with a total of 0.4 milligrams of THC per container will remain legal starting November 12.
in April, the president himself has asked members of Congress to redefine hemp to prevent the recriminalization of full-spectrum CBD products.
“I call on Congress to update the Act so that Americans can continue to have access to the full-spectrum CBD products they trust and support, while upholding Congress’ intent to limit the sale of products that pose health risks,” Trump said in a Truth Social post the same day his administration announced it was moving forward with marijuana reregulation.
“We need to do this RIGHT and FAST, especially for those who have found CBD to help them,” he said. “Also, I’m told it will help our BIG FARMERS that we love and will always be around.”
Industry advocates say the law passed last year not only threatens to ban intoxicating and synthetic cannabinoids, but also take popular full-spectrum CBD products used therapeutically by many Americans off the market.
“ONE IN FIVE adults used it in the past year, and many say it dramatically improved their chronic pain,” the president said in the social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.”
The administration also referred to a new initiative launched in April Cover up to $500 of hemp-derived products annually for eligible Medicare patients. The program being implemented by the Centers for Medicare and Medicaid Services (CMS) focuses largely on CBD, but allows products to contain a total of 3 milligrams of THC per serving.
“In December, I signed a very important Executive Order calling for Research and Innovation into Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved quickly to follow the Executive Order directive, and set a model in motion for some Seniors this month. But more needs to be done!”
“Please do it, and SOON,” the president said, referring to the sweeping recriminalization congressional fix that will take effect in November. “Thank you for your attention to this matter!”
It’s unclear how far Trump wants to reduce the scope of planned federal restrictions on hemp products and what kinds of revised THC rules and limits he’d prefer to sign into law.
Separately, White House officials recently briefed a congressional office on hemp regulation.
In April, Vince Haley, director of the White House Domestic Policy Council, and James Braid, assistant to the president for legislative affairs, sent Barr hemp policy suggestions.
“We appreciate your work to advance policy,” the executive order Trump signed in December, which included provisions to protect Americans’ access to CBD products, the staff wrote in a letter to Congress.
“We are submitting draft legislation and comments to your account to address the final statutory definition of hemp-derived cannabinoid products to ensure that Americans have access to adequate full-spectrum CBD products while maintaining Congress’ intent to limit the sale of products that pose serious health risks,” White House officials said, according to a social media screencast. “We are open to discussion and further technical assistance.”
Separately, Anti-marijuana organizations filed a lawsuit against the Medicare hemp CBD coverage policy– but adjudge dismissed the suit last month, ruling they lack standing. Health and Human Services lawyers section. Robert F. Kennedy Jr. and CMS director Mehmet Oz He filed a letter requesting that the case be dismissed.
The White House Management and Budget Office has also held a series of meetings a Food and Drug Administration (FDA) CBD product enforcement policy.
The FDA issued the guidance making it clear that it does not intend to interfere Establish a Medicare coverage plan for hemp-derived products.
CMS finalized a rule that will be adopted separately Coverage of certain hemp products, primarily as specialized health-related benefits, through Medicare Advantage the plans
As hemp products become more popular among consumers, some big brands are trying to get in on the action.
The main retailer Target, for example, is expanding its market share of hemp-derived THC beverages. Last year, the company began a pilot program selling cannabis beverages at 10 stores in Minnesota. That apparently went well, and now the company has secured licenses from Minnesota regulators to sell lower-potency edible hemp products — including THC drinks — in 72 stores in the state.
The National Restaurant Association, which represents the industry, just sent a letter to congressional leaders asking for it delaying the federal recriminalization of hemp THC beverages It will come into effect at the end of the year and will be replaced by a regulatory framework that “meets growing market demand while ensuring consumer safety” as an alternative to alcohol in products.
A report from the US Department of Agriculture published in April shows this US farmers grow $3 billion in hemp crops by 2025— 64% increase compared to the previous year.
Read the White House the letter To the conference below: